Open AccessTherapeutic Options for CML Patients Who Fail All TKIs
Author(s) -
Mark L. Fuerst
Publication year - 2018
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000535070.58008.f6
Subject(s) - medicine , chronic myelogenous leukemia , nilotinib , oncology , imatinib , leukemia , myeloid leukemia